GENFIT (EPA:GNFT) | Finanzwire

Basculer en Français

8295	Companies
114831	Keywords
55272	Articles
62429	Press releases

Home
Companies
GENFIT

BRIEF

published on 11/07/2024 at 22:15, 13 days 12 hours ago

GENFIT Reports Third Quarter 2024 Financial Update

Revenue Growth PBC Treatment GENFIT Financials Cash Position 2024 Ipsen Collaboration
PRESS RELEASE

published on 11/07/2024 at 22:10, 13 days 12 hours ago

GENFIT Reports Third Quarter 2024 Financial Information
GENFIT reports €59.7M revenue for Q3 2024 with €96.0M cash. Focus on liver diseases. Results surpass 2023

Revenue Cash Position Q3 2024 Liver Diseases GENFIT
PRESS RELEASE

published on 09/19/2024 at 22:10, 2 months 1 day ago

GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update
BRIEF

published on 07/26/2024 at 13:50, 3 months 25 days ago

GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® in Primary Biliary Cholangitis

GENFIT EMA Iqirvo® Elafibranor PBC Treatment
PRESS RELEASE

published on 07/26/2024 at 13:45, 3 months 25 days ago

GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis
GENFIT receives positive opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis, awaiting final European Commission decision. Details in press release

GENFIT PBC Treatment Positive Opinion EMA Committee Ipsen's Iqirvo
BRIEF

published on 07/09/2024 at 22:15, 4 months 11 days ago

GENFIT Announces Half-Year Liquidity Contract Report with Crédit Industriel et Commercial

Liquidity Contract Shares Biopharmaceutical GENFIT Trading Report
PRESS RELEASE

published on 07/09/2024 at 22:10, 4 months 11 days ago

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
GENFIT announces half-year report of liquidity contract with Crédit Industriel et Commercial, revealing trading details and resources as of June 30, 2024

Liquidity Contract Crédit Industriel Et Commercial GENFIT Resources Trading Details
BRIEF

published on 06/17/2024 at 22:15, 5 months 3 days ago

GENFIT: NIS2+® Included in New Clinical Guidelines for MASLD

GENFIT MASH NIS2+® MASLD Clinical Guidelines
PRESS RELEASE

published on 06/17/2024 at 22:10, 5 months 3 days ago

GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH
GENFIT announces inclusion of NIS2+® in new EASL-EASD-EASO Clinical Practice Guidelines for MASLD, as a key tool for detecting at-risk MASH. Guidelines provide update on prevention, screening, diagnosis, follow-up, and treatment for MASLD

GENFIT MASH NIS2+® MASLD EASL-EASD-EASO
BRIEF

published on 06/10/2024 at 23:27, 5 months 10 days ago

GENFIT: Accelerated approval of Iqirvo® by the FDA for Primary Biliary Cholangitis

FDA Biopharmaceutical Primary Biliary Cholangitis GENFIT Iqirvo

Accesswire

Published on 11/21/2024 at 10:03, 34 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 37 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 37 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 2 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 12 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:04, 32 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 34 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 36 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 36 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 09:01, 1 hour 35 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 39 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 16 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 52 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 52 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE